Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
27.14
-2.05 (-7.02%)
At close: Jan 16, 2026, 4:00 PM EST
27.15
+0.01 (0.04%)
After-hours: Jan 16, 2026, 7:57 PM EST
Olema Pharmaceuticals Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$41.14
Upside
+51.58%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +65.81% | Jan 7, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $21 → $60 | Strong Buy | Maintains | $21 → $60 | +121.08% | Dec 12, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $45 → $48 | Buy | Maintains | $45 → $48 | +76.86% | Dec 11, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $26 → $38 | Strong Buy | Maintains | $26 → $38 | +40.01% | Dec 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $45 | Strong Buy | Maintains | $36 → $45 | +65.81% | Dec 11, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $18 → $26 | Strong Buy | Maintains | $18 → $26 | -4.20% | Nov 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $36 | Strong Buy | Maintains | $28 → $36 | +32.65% | Nov 18, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $22 → $45 | Buy | Maintains | $22 → $45 | +65.81% | Nov 18, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $29 → $32 | Buy | Maintains | $29 → $32 | +17.91% | Nov 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +3.17% | Oct 20, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | -26.31% | Oct 8, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $22 | Buy | Maintains | $22 | -18.94% | Sep 3, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $28 → $29 | Buy | Maintains | $28 → $29 | +6.85% | Aug 14, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $20 → $21 | Strong Buy | Maintains | $20 → $21 | -22.62% | Aug 12, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | -33.68% | May 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $25 → $22 | Buy | Maintains | $25 → $22 | -18.94% | May 14, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.